PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
Public ClinicalTrials.gov record NCT02226965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It is a multi-center, nonrandomized, open label, phase II investigation of PNT2258 to characterize anti-tumor activity and collect safety data on patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma.
Study identification
- NCT ID
- NCT02226965
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2014 (Actual)
- Primary completion
- Jul 11, 2016 (Actual)
- Completion
- Aug 22, 2018 (Actual)
- Last update posted
- Jun 29, 2023
2014 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Long Beach Memorial Medical Center | Long Beach | California | 90806 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Colorado Blood and Cancer Institute | Denver | Colorado | 80218 | — |
| Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| Bond Clinic, P.A. | Winter Haven | Florida | 33880 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Horizon Oncology Research, Inc. | Lafayette | Indiana | 47905 | — |
| UHC Oncology | Lafayette | Louisiana | 70506 | — |
| Western Maryland Health System | Cumberland | Maryland | 21502 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Mercy Health Saint Mary's | Grand Rapids | Michigan | 49503 | — |
| St. John Hospital and Medical Center | Grosse Pointe Woods | Michigan | 48236 | — |
| Michigan State University | Lansing | Michigan | 48910 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Bon Secours Saint Francis Cancer Center | Greenville | South Carolina | 29607 | — |
| Avera Research Institute | Sioux Falls | South Dakota | 57108 | — |
| Baylor Research Institute | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Tyler Hematology Oncology | Tyler | Texas | 75701 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | — |
| Medical Oncology Associates, PS | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02226965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02226965 live on ClinicalTrials.gov.